Prevalence of Organic Colonic Lesions by Colonoscopy in Patients Fulfilling ROME IV Criteria of Irritable Bowel Syndrome
DOI:
https://doi.org/10.31729/jnma.3367Abstract
Introduction: Irritable bowel syndrome occurs as recurrent abdominal pain that is related to defecation and associated with change in frequency and/or form of stool. Few Patients with IBS may have organic lesions detectable at colonoscopy.
Methods: A cross sectional study was carried out in 140 consecutive patients of IBS fulfilling the ROME IV criteria. The study was conducted in Gastroenterology unit, Department of Medicine, Bir hospital, Kathmandu from July 2016 to September 2017. All patients underwent full colonoscopy along with biopsy from sigmoid colon and any visibly abnormal areas.
Results: The average age of patients was 37.5 years with 76 (52.8%) males. Forty-two (30%) had IBS-D, 36 (26%) had IBS-C, 31 (22%) had IBS-M and 31 (22%) had IBS-U. Dyspepsia was seen in 16 (11.4%) and fear of TB/Malignancy/IBD was seen in 27 (19.2%). Organic lesions were seen in 39 (27.85%) patients. Nonspecific colitis was seen in 10 (7.1%) followed by ileal erosions in 7 (5%), polyps in 8 (5.7%), hemorrhoids in 6 (4.2%) and diverticula in 3 (2.1%). Only one (0.71%) patient had microscopic colitis and one (0.71%) had malignant lesion seen at histopathological examination. Females with IBS-D had more organic findings than males (P=0.03, RR=4.13, 95% CI=1.21-15.71).
Conclusions: The prevalence of organic lesions in patients with IBS fulfilling ROME IV criteria is 27%. Dyspepsia is the most common comorbidity and fear of TB/malignancy/IBD is the most common reason for seeking health care. Females with IBS-D have a higher risk of detecting organic lesions by colonoscopy and histopathology examination.
References
2. Vanner S, Depew W, Paterson W, DaCosta L, Groll A, Simon J, et al. Predictive value of the Rome criteria for diagnosing the irritable bowel syndrome. Am J Gastroenterol. 1999 Oct;94(10):2912-7. [PubMed | DOI | Full Text]
3. Ford AC, Chey WD, Talley NJ, Malhotra A, Spiegel BM, Moayyedi P. Yield of diagnostic tests for celiac disease in individuals with symptoms suggestive of irritable bowel syndrome: systematic review and meta-analysis. Arch Intern Med. 2009 Apr 13;169(7):651-8. [PubMed | DOI | Full Text]
4. Pardi DS, Limsui D. Utility of symptom-based criteria for evaluating patients with chronic diarrhea.Gastrointest Endosc. 2005 Oct;62(4):649.[PubMed | DOI | Full Text]
5. Chey WD, Kurlander J, Eswaran S. Irritable bowel syndrome: a clinical review. JAMA. 2015 Mar 3;313(9):949-58. [PubMed | DOI | Full Text]
6. Riedl A, Schmidtmann M, Stengel A, Goebel M, Wisser A-S, Klapp BF, et al. Somatic comorbidities of irritable bowel syndrome: a systematic analysis.J Psychosom Res. 2008 Jun;64(6):573-82. [PubMed | DOI | Full Text]
7. Akhtar AJ, Shaheen MA, Zha J. Organic colonic lesions in patients with irritable bowel syndrome (IBS). Med SciMonit. 2006 Sep;12(9):CR363-7. [PubMed | Full Text]
8. Patel P, Bercik P, Morgan DG, Bolino C, Pintos-Sanchez MI, Moayyedi P, et al. Prevalence of organic disease at colonoscopy in patients with symptoms compatible with irritable bowel syndrome: cross-sectional survey. Scand J Gastroenterol. 2015 Jul;50(7):816-23. [PubMed | DOI | Full Text]
9. Park KS, Ahn SH, Hwang JS, Cho KB, Chung WJ, Jang BK, et al. A survey about irritable bowel syndrome in South Korea: prevalence and observable organic abnormalities in IBS patients.Dig Dis Sci. 2008 Mar;53(3):704-11.[PubMed | Full Text]
10. Gu H-X, Zhang Y-L, Zhi F-C, Jiang B, Huang Y. Organic colonic lesions in 3,332 patients with suspected irritable bowel syndrome and lacking warning signs, a retrospective case–control study. Int J Colorectal Dis. 2011 Jul;26(7):935-40. [PubMed| Full Text]
11. Chey WD, Nojkov B, Rubenstein JH, Dobhan RR, Greenson JK, Cash BD. The yield of colonoscopy in patients with non-constipated irritable bowel syndrome: results from a prospective, controlled US trial. Am J Gastroenterol. 2010 Apr;105(4):859-65. [PubMed |Full Text]
12. Ishihara S, Yashima K, Kushiyama Y, Izumi A, Kawashima K, Fujishiro H, et al. Prevalence of organic colonic lesions in patients meeting Rome III criteria for diagnosis of IBS: a prospective multi-center study utilizing colonoscopy. J Gastroenterol. 2012 Oct;47(10):1084-90. [PubMed |Full Text]
13. Lacy BE, Mearin F, Chang L, Chey WD, Lembo AJ, Simren M, et al. Bowel disorders. Gastroenterology.2016;150(6):1393-407.e5. [Full Text | DOI | PubMed]
14. Lewis S, Heaton K. Stool form scale as a useful guide to intestinal transit time.Scand J Gastroenterol. 1997 Sep;32(9):920-4. [PubMed |Full Text]
15. Whitehead WE, Palsson OS, Levy RR, Feld AD, Turner M, Von Korff M. Comorbidity in irritable bowel syndrome. Am J Gastroenterol. 2007 Dec;102(12):2767-76.[PubMed | Full Text].
16. Yao X, Yang YS, Cui LH, Zhao KB, Zhang ZH, Peng LH, et al. Subtypes of irritable bowel syndrome on Rome III criteria: a multicenter study. J Gastroenterol Hepatol. 2012 Apr;27(4):760-5. [PubMed | Full Text]
17. Masud MA, Hasan M, Khan AK. Irritable bowel syndrome in a rural community in Bangladesh: prevalence, symptoms pattern, and health care seeking behavior. Am J Gastroenterol. 2001May;96(5):1547-52. [PubMed |Full Text]
18. Sperber AD, Dumitrascu D, Fukudo S, Gerson C, Ghoshal UC, Gwee KA, et al. The global prevalence of IBS in adults remains elusive due to the heterogeneity of studies: a Rome Foundation working team literature review. Gut. 2016:gutjnl-2015-311240. [PubMed |Full Text]
19. Chang FY, Lu CL, Chen TS. The current prevalence of irritable bowel syndrome in Asia.J Neurogastroenterol Motil. 2010Oct;16(4):389-400. [Full Text | PubMed]
20. Jafei W, Yakoob J, Jafri N, Maloni M, Hamid S, Shah HA, et al. Irritable bowel syndrome in health care professionals in Pakistan. JPMA The Journal of the Pakistan Medical Association. 2003;53(9):405-7. [Full Text | PubMed]
21. Hoeper EW, Nycz GR, Regier DA, Goldberg ID, Jacobson A, Hankin J. Diagnosis of mental disorder in adults and increased use of health services in four outpatient settings. Am Psychiatry. 1980 Feb;137(2):207-10. [Full Text | DOI | PubMed]
22. Talley NJ, Boyce PM, Jones M. Predictors of health care seeking for irritable bowel syndrome: a population based study. Gut. 1997 Sep;41(3):394-8. [PubMed]
23. Akhtar AJ, Shaheen MA, Zha J. Organic colonic lesions in patients with irritable bowel syndrome (IBS).Med SciMonit. 2006 Sep;12(9):CR363-7. [ Full Text | PubMed ]
24. Pironti A, Tadeu V, Pedroni A, Porcu A, Manca A, Massarelli G, et al. Role of routine small intestinal biopsy in adult patient with irritable bowel syndrome-like symptoms.Minerva Med. 2010 Jun;101(3):129-34. [ Full Text | PubMed ]
25. Yamada E, Inamori M, Uchida E, Tanida E, Izumi M, Takeshita K, et al. Association between the location of diverticular disease and the irritable bowel syndrome: a multicenter study in Japan. Am J Gastroenterol. 2014 Dec;109(12):1900-5. [ Full Text | DOI | PubMed ]
26. Ozdil K, Sahin A, Calhan T, Kahraman R, Nigdelioglu A, Akyuz U, et al. The frequency of microscopic and focal active colitis in patients with irritable bowel syndrome.BMC Gastroenterol. 2011; 11: 96. [ Full Text | DOI | PubMed ]
27. Vork L, Weerts ZZ, Mujagic Z, Kruimel JW, Hesselink MA, Muris JW, Keszthelyi D, Jonkers DM, Masclee AA. Rome III vs Rome IV criteria for irritable bowel syndrome: A comparison of clinical characteristics in a large cohort study. NeurogastroenterolMotil. 2017 Aug 14. [ Full Text | DOI | PubMed ]
28. Lovell RM, Ford AC. Effect of gender on prevalence of irritable bowel syndrome in the community: systematic review and meta-analysis.Am J Gastroenterol. 2012 Jul;107(7):991-1000. [ DOI | PubMed ]
Downloads
Published
How to Cite
Issue
Section
License
JNMA allow to read, download, copy, distribute, print, search, or link to the full texts of its articles and allow readers to use them for any other lawful purpose. The author(s) are allowed to retain publishing rights without restrictions. The JNMA work is licensed under a Creative Commons Attribution 4.0 International License. More about Copyright Policy.
